Regulation News
Malliotakis backs EPIC Act: ‘Treating small-molecule drugs differently from biologics does not make sense’
U.S. Representative Nicole Malliotakis (R-NY) has voiced concerns over the potential negative impact of the "pill penalty" provision within President Biden's Inflation Reduction Act on the biopharma industry, particularly in the New York City metro area.
New York attorney who sued the FDA: 'I'm talking about safety and advocacy from a civil and individual rights perspective'
At last month’s Novel Coronavirus Southwestern Intergovernmental Committee hearing, civil rights attorney Aaron Siri said the Food and Drug Administration (FDA) should be a cold, hard and independent regulatory agency that looks at data clinically to decide whether a vaccine is safe and effective.
Latest News
